Volitionrx VNRX
NYSE VNRX
$0.32 -0.01 (-2.20%)
As of: Sep 9, 2026 · 1:01 PM EDT

Volitionrx (VNRX) Cost of Revenue (2019)

Volitionrx's (VNRX) quarterly Cost of Revenue came in at $892.0 in Q3 2019.

Analysis

Volitionrx (VNRX) Cost of Revenue (2019) Analysis & Trends

Volitionrx (VNRX) has reported Cost of Revenue for 1 consecutive years, with $892.0 the latest figure, recorded in Q3 2019.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cost of Rev (Qtr)
1 GE HealthCare Technologies 29.78 Bn 27.67 Bn 2.18 Bn 2.25 Bn
2 Lantheus Holdings 6.58 Bn 5.99 Bn 241.86 Mn 146.33 Mn
3 Heartflow 4.11 Bn 3.74 Bn 53.19 Mn 10.89 Mn
4 Neogen 2.60 Bn 2.41 Bn 107.80 Mn 117.50 Mn
5 Butterfly Network 1.99 Bn 1.86 Bn 23.29 Mn 9.32 Mn
6 Ceribell 921.90 Mn 792.63 Mn 25.94 Mn 2.16 Mn
7 QuidelOrtho 886.88 Mn 763.48 Mn - -
8 Varex Imaging 779.06 Mn 679.86 Mn 76.70 Mn 133.80 Mn
9 Prenetics Global 338.37 Mn 279.32 Mn 30.20 Mn 16.29 Mn
10 Volitionrx 1.16 Mn -1.63 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2019 892.00